cost-efficient-transcriptomic-based-drug-screening

Cost-Efficient Transcriptomic-Based Drug Screening

Transcriptomics allows&#160;to obtain comprehensive insights into cellular programs and their responses to perturbations. Despite a significant decrease ...

DZNE and University of Bonn

Disease recovery dynamics are often difficult to assess, as patients display heterogeneous recovery courses. To model recovery dynamics, exemplified by severe COVID-19, we apply a computational scheme on longitudinally sampled blood transcriptomes, generating recovery states, which we then link to cellular and molecular mechanisms, presenting a framework for studying the kinetics of recovery compared with non-recovery over time and long-term effects of the disease. Specifically, a decrease in mature neutrophils is the strongest cellular effect during recovery, with direct implications on disease outcome. Furthermore, we present strong indications for global regulatory changes in gene programs, decoupled from cell compositional changes, including an early rise in T cell activation and differentiation, resulting in immune rebalancing between interferon and NF-κB activity and restoration of cell homeostasis. Overall, we present a clinically relevant computational framework for modeling disease recovery, paving the way for future studies of the recovery dynamics in other diseases and tissues.

Heidi Theis

PRECISE Platform for Single Cell Genomics and Epigenomics

DZNE and University of Bonn

Cost-Efficient Transcriptomic-Based Drug Screening

Heidi Theis

.css-o250i3{font-size:18px;font-family:Open Sans,sans-serif;line-height:21.6px;}PRECISE Platform for Single Cell Genomics and Epigenomics

DZNE and University of Bonn

Cost-Efficient Transcriptomic-Based Drug Screening

PRECISE Platform for Single Cell Genomics and Epigenomics